This enhancement introduces separate signature field types for Patient and Other within Consent letter templates. Practices can now capture and track patient and non-patient signatures independently throughout the consent workflow, including forms completed through Kiosk, improving documentation accuracy and flexibility.
This enhancement introduces a configurable Weight Cap for eligible weight-based drugs, allowing practices to define a maximum weight used for dosage calculations. When a patient's recorded weight exceeds the configured threshold, the system automatically applies the capped weight during dose calculations and displays visual indicators throughout oncology workflows to identify capped dosing.
This enhancement introduces a redesigned Drug Forecasting Report that provides a more comprehensive view of upcoming medication requirements for oncology practices. The report includes enhanced forecasting, advanced filtering, patient-level details, improved NDC management, alternative drug selection, and expanded print and export capabilities to support inventory planning and reduce medication waste.
This enhancement significantly expands the Clinical Trials Research Module by providing a centralized workspace for managing research data, trial documentation, sign-off workflows, and consolidated reporting. The updated module introduces new research sections, streamlined trial summary creation, enhanced report management, and improved collaboration for clinical research teams.
This enhancement introduces the Therapies Nearing Completion report within the Chemotherapy Manager Dashboard. The report enables practices to proactively identify patients whose chemotherapy therapies are approaching completion, helping providers review and extend treatment plans without relying on manual chart reviews.
This enhancement introduces a practice-level setting that allows organizations to enforce or optionally prompt appointment linking when creating Provider Notes on the same Date of Service (DOS). The feature improves encounter accuracy by ensuring provider notes are associated with the appropriate appointment while maintaining configurable workflow flexibility.
This enhancement introduces a new Patient option in the Responsible Plan filter of the General Service Analysis report. Users can now generate reports specifically for Self-Pay appointments, making it easier to analyze patient balances and payments without including insurance-responsible appointments.
This enhancement automates the maintenance of the Rejected and Corrected claim work queues by removing claims once they have been processed through payment, denial, or insurance updates. The system also restores claims to the appropriate queue if the triggering transaction is reversed, reducing manual cleanup and improving claim management accuracy.
This enhancement ensures that patient comments entered in the Lab Results Beta View are displayed consistently across all supported lab result report templates. Both test-level and overall patient comments are included in printed reports when the appropriate preference is enabled, providing a consistent reporting experience regardless of the template used.
This enhancement introduces safeguards that prevent Location-level Address and Time Zone changes after a location exceeds the configured successful appointment threshold. These restrictions help maintain synchronization between CureMD and Leap by preserving consistent location information for existing and future appointments.
Posted On: Jul 30, 2026
Posted On: Jul 22, 2026
Posted On: Jul 21, 2026
Posted On: Jul 21, 2026
Posted On: Jul 14, 2026
Posted On: Jul 14, 2026